HomeNewsBusinessIndian Railways extends deadline for bids for 200 third-generation Vande Bharat train sets to October

Indian Railways extends deadline for bids for 200 third-generation Vande Bharat train sets to October

The Railway Ministry’s decision to extend the deadline may affect the government’s ambitious plan to manufacture 400 Vande Bharat trains in India by the end of 2024-25.

July 07, 2022 / 16:40 IST
Story continues below Advertisement
Vande Bharat express
Vande Bharat express

Indian Railways has extended the deadline for a tender that it released for 200 third-generation Vande Bharat train sets. The deadline for bid submission for key systems has been extended to October 10 from July 26.

The deadline has been extended because industry stakeholders sought additional time to evaluate the project and prepare their bids, a senior railway official said.

Story continues below Advertisement

ALSO READ: Indian Railways to come out with tender for 200 fourth-generation Vande Bharat trains by August

“Some private players have asked for more time to evaluate the investment needed to upgrade existing infrastructure at Marathwada Rail Coach Factory in Latur and the Integral Coach Factory in Chennai,” the official said.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show